This stock is no longer traded. It was delisted on July 10, 2026. Prices stop on that date; discussion is still counted.
Generated by AI
Allurion Technologies Inc. is a healthcare-focused company dedicated to developing non-invasive medical devices and technology solutions aimed at promoting weight loss and healthy living. The cornerstone of Allurion's offerings is the Elipse Balloon, a swallowable, intragastric balloon designed to aid in weight loss without the need for surgery or endoscopic procedures. This innovative device gradually inflates within the stomach, providing a temporary sense of fullness to patients, which helps reduce food intake. Allurion operates primarily within the medical technology and wellness sectors, targeting a global market that includes hospitals, clinics, and wellness centers. With obesity being a significant health concern worldwide, Allurion's non-surgical solutions garner attention for their potential impact on improving patient outcomes while reducing healthcare costs associated with obesity-related conditions. The company continues to evolve its technological platforms, incorporating digital tools to monitor and support patients throughout their weight loss journey, cementing its position in the intersection of health, technology, and consumer healthcare markets.
Website11 Huron Drive
Natick, MA, 01760
United States
Summary of Mar 3's posts. Generated by AI.
Summary of Feb 24's posts. Generated by AI.
Summary of Mar 2's posts. Generated by AI.
Investors talking about ALUR also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.